Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 01/01/2008
Publisher: CLSI
File Format: PDF
$90.00$180.00
Published:01/01/2008
Pages:64
File Size:1 file , 1.5 MB
Note:This product is unavailable in Russia, Belarus
This document contains a protocol that optimizes the experimental design for the evaluation of qualitative tests, to better measure performance and provide a structured data analysis.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
Design and Validation of Immunoassays for Assessment of Human Allergenicity of New Biotherapeutic Drugs; Approved Guideline, I/LA34AE
$129.00 $259.27
Procedures for the Erythrocyte Sedimentation Rate Test; Approved Standard - Fifth Edition, H02A5
$90.00 $180.00
Establishing Molecular Testing in Clinical Laboratory Environments; Proposed Guideline, MM19P
$115.00 $231.51
Pulse Oximetry; Approved Guideline, Second Edition, POCT11A2
$131.00 $263.58
